drugset / Trial / NCT05351905
Improving Pain Disability With the Use of Oral Cannabinoids
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators are conducting a pilot (i.e. a small study) in order to find out the effectiveness and safety of medical cannabis in the management of chronic pain. At the end of this 3 month study, investigators will gather information on how easy it is for patients to enroll and complete the entire study. The results of this pilot study will help the study team design a larger randomized controlled trial.
Timeline
- Start
- 2022-11-22
- Primary completion
- 2025-12-31
- Completion
- 2026-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 150 mg | Oral |
| Subject | Cannabidiol | Other / unclassified | 300 mg | Oral |
| Subject | ∆9-tetrahydrocannabidiol | Unknown | 12 mg | Oral |
| Subject | ∆9-tetrahydrocannabidiol | Unknown | 30 mg | Oral |